Parrini, I.; Ceravolo, R.; Rao, C.M.; Lucà , F.; Gulizia, M.M.; Gelsomino, S.; Ingianni, N.; Carullo, G.; Quartuccio, S.; Renne, S.;
et al. SGLT2 Inhibitors in Elderly Patients: Clinical Perspectives from Metabolic and Cardiorenal Protection to Implementation. J. Clin. Med. 2026, 15, 4578.
https://doi.org/10.3390/jcm15124578
AMA Style
Parrini I, Ceravolo R, Rao CM, Lucà F, Gulizia MM, Gelsomino S, Ingianni N, Carullo G, Quartuccio S, Renne S,
et al. SGLT2 Inhibitors in Elderly Patients: Clinical Perspectives from Metabolic and Cardiorenal Protection to Implementation. Journal of Clinical Medicine. 2026; 15(12):4578.
https://doi.org/10.3390/jcm15124578
Chicago/Turabian Style
Parrini, Iris, Roberto Ceravolo, Carmelo Massimiliano Rao, Fabiana Lucà , Michele Massimo Gulizia, Sandro Gelsomino, Nadia Ingianni, Giuseppe Carullo, Sebastiano Quartuccio, Stefania Renne,
and et al. 2026. "SGLT2 Inhibitors in Elderly Patients: Clinical Perspectives from Metabolic and Cardiorenal Protection to Implementation" Journal of Clinical Medicine 15, no. 12: 4578.
https://doi.org/10.3390/jcm15124578
APA Style
Parrini, I., Ceravolo, R., Rao, C. M., Lucà , F., Gulizia, M. M., Gelsomino, S., Ingianni, N., Carullo, G., Quartuccio, S., Renne, S., Bilato, C., Geraci, G., Oliva, F., Nardi, F., & Grimaldi, M.
(2026). SGLT2 Inhibitors in Elderly Patients: Clinical Perspectives from Metabolic and Cardiorenal Protection to Implementation. Journal of Clinical Medicine, 15(12), 4578.
https://doi.org/10.3390/jcm15124578
